Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 11/2004

01-11-2004 | Original Article

An estimate of the worldwide prevalence, mortality and disability associated with hip fracture

Authors: O. Johnell, J. A. Kanis

Published in: Osteoporosis International | Issue 11/2004

Login to get access

Abstract

The aim of this study was to quantify the global burden of osteoporosis as judged by hip fracture and the burden in different socio-economic regions of the world. The population mortality in 1990 and the incidence of hip fracture in different regions were identified, where possible in 1990. Excess mortality from hip fracture used data for Sweden, and disability weights were assigned to survivors from hip fracture. In 1990 there were an estimated 1.31 million new hip fractures, and the prevalence of hip fractures with disability was 4.48 million. There were 740,000 deaths estimated to be associated with hip fracture. There were 1.75 million disability adjusted life-years lost, representing 0.1% of the global burden of disease world-wide and 1.4% of the burden amongst women from the established market economies. We conclude that hip fracture is a significant cause of morbidity and mortality worldwide.
Literature
1.
De Laet CE, van Hout BA, Hofman A, Pols HA (2002) [Costs due to osteoporosis-induced fractures in The Netherlands; possibilities for cost control]. Nederlands Tijdschrift voor Geneeskunde, CBO, Utrecht
2.
Kanis JA, Pitt FA (1992) Epidemiology of osteoporosis. Bone 13:S7–S15
3.
Lau EMC, YH Chan, M Chan, J Woo, J Griffith, HHL Chan, PC Leung (2000) Vertebral deformity in Chinese men: prevalence, risk factors, bone mineral density and body composition measurements. Calcif Tissue Int 66:47–52
4.
Johnell O (1997) The socioeconomic burden of fractures: today and in the 21st century. Am J Med 103:20S–25S; discussion 25S–26S
5.
Randell A, Sambrook PN, Nguyen TV, Lapsley H, Jones G, Kelly PJ, Eisman JA (1995) Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int 5:427–432
6.
Ray NF, Chan JK, Thamer M, Melton LJ III (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35
7.
Fox Ray N, Chan JK, Thamer M, Melton III LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35
8.
Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
9.
Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413
10.
Murray CJL, Lopez AD (1996) Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 countries. Harvard School of Public Health, USA
11.
Murray CJL (1996) Rethinking DALYs. In: Murray CJL, Lopez AD (eds) The global burden of disease. WHO, Geneva, pp 1–89
12.
World Bank (1993) World development report 1993. Investing in health. Oxford University Press, New York
13.
Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge, Mass.
14.
Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SC, Jonsson PV, Poor G, Sisson de Castro JA, Xu L, Matkin CC, Nelson LM, Heyse SP (1999) International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization programme for research on ageing. Osteoporos Int 9:242–253
15.
Ling X, Aimin L, Xihe Z, Xiaoshu C, Cummings SR (1996) Very low rates of hip fracture in Beijing, People’s Republic of China. The Beijing Osteoporosis Project. Am J Epidemiol 144:901–907
16.
Yan L, Zhon B, Prentice A, Wang X, Golden MHN (1999) Epidemiological study of hip fracture in Shenyang, People’s Republic of China. Bone 24:151–155
17.
Memon A, Pospula WM, Tantawy AY, Abdul-Ghafar S, Suresh A (1998) Incidence of hip fracture in Kuwait. Int J Epidemiol 27:860–865
18.
Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1998) Lifetime risk of hip fractures is underestimated. Osteoporos Int 8:599–603
19.
Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK (2003) The components of excess mortality after hip fracture. Bone 32:468–473
20.
Parker MJ, Anand JK (1991) What is the time mortality of hip fractures. Public Health 105:443–446
21.
Murray CJL, Lopez AP (1996) Global and regional descriptive epidemiology of disability: Incidence, prevalence, health expectancies and years lived with disability. In: Murray CJL, Lopez AD (eds) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge University Press, Cambridge, pp 201–246
22.
National Osteoporosis Foundation (1998) Osteoporosis: cost effectiveness analysis and review of the evidence for prevention, diagnosis and treatment. Osteoporos Int 8: S1–S88
23.
Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2000) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427
24.
Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2003) Risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20–26
25.
Williams A (1999) Calculating the global burden of disease. Time for a strategic reappraisal. Health Econ 8:1–8
26.
Cooper C, Atkinson EJ, Jacobson SJ, O’Fallon WM et al. (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001–1005
27.
Magaziner J, Simonsick EM, Kasher TM, Hebel JR et al. (1989) Survival experience of aged hip fracture patients. Am J Public Health 79:274–278
28.
Poor G, Atkinson EJ, O’Fallon WM, Melton LJ (1995) Determinants of reduced survival following hip fractures in men. Clin Orthop Rel Res 319:260–265
29.
Lopez Vaz A (1993) Epidemiology and costs of osteoporotic hip fractures in Portugal. Bone 14:S9
30.
Brazier J, Green C, Kanis JA on behalf of the Committee of Scientific Advisors, International Osteoporosis Foundation 2002 (2002) A systematic review of health state utility values for osteoporosis. Osteoporos Int 13:768–776
Metadata
Title
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture
Authors
O. Johnell
J. A. Kanis
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 11/2004
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-004-1627-0

Other articles of this Issue 11/2004

Osteoporosis International 11/2004 Go to the issue

Original Article

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

Original Article

Establishing the compliance in elderly women for use of a low level mechanical stress device in a clinical osteoporosis study

Original Article

Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis

Original Article

Role of sex steroids in the regulation of bone morphology in men. The MINOS study

Original Article

Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture

Original Article

No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.